Report | Ending the neglect - Cost-benefit analysis of eliminating NTDs in Nigeria by 2030
The report’s main objective is to holistically present the key economic and social benefits of eliminating the five most prevalent NTDs in Nigeria by 2030, including long-term financial returns and a cost-benefit assessment of elimination programs.
NTDs remain a severe problem in Nigeria, which accounts for around 25% of Africa’s NTD cases. According to the WHO, 165 million people in Nigeria (i.e., 84% of the population) require preventive chemotherapy for at least one NTD. One of the reasons for this is the lack of access to clean water and sanitation.
Only 14% of the Nigerian population has access to safely managed drinking water sources, and 44% has access to sanitation, with open defecation still prevalent. Only 17% of the population uses improved sanitation facilities with hand washing facilities and soap.